Showing results (1391-1400 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|May 16, 2006
A Phase II trial of epothilone B analogue BMS-247550 (NSC #710428) ixabepilone, in patients with advanced pancreas cancer: a Southwest Oncology Group studyRobert P Whitehead, Sheryl McCoy, Saul E Rivkin, et al.Investigational New Drugs|April 25, 2006
Proteomic analysis of prodigiosin-induced apoptosis in a breast cancer mitoxantrone-resistant (MCF-7 MR) cell lineMarta Monge, Marta Vilaseca, Vanessa Soto-Cerrato, et al.Investigational New Drugs|December 2, 2022
A prospective multicenter phase II study of FOLFIRINOX as a first-line treatment for patients with advanced and recurrent biliary tract cancerNaminatsu Takahara, Yousuke Nakai, Hiroyuki Isayama, et al.Investigational New Drugs|January 1, 1987
The colony inhibition of a new chemotherapeutic agent (KW2152) against human lung cancer cell linesJ R Jett, N Saijo, W S Hong, et al.Investigational New Drugs|January 1, 1987
The PIT method: an automated in vitro technique for drug toxicity testingR van Lambalgen, P LelieveldInvestigational New Drugs|July 8, 2022
Brain pharmacokinetics and metabolism of the AMP-activated protein kinase selective inhibitor SBI-0206965, an investigational agent for the treatment of glioblastomaJanki M Desai, Aniruddha S Karve, Gary A Gudelsky, et al.Investigational New Drugs|November 30, 2019
Matteucinol, isolated from Miconia chamissois, induces apoptosis in human glioblastoma lines via the intrinsic pathway and inhibits angiogenesis and tumor growth in vivoAna Gabriela Silva, Viviane Aline O Silva, Renato J S Oliveira, et al.Investigational New Drugs|November 16, 2019
A pilot study on intermittent every other days of 5-dose Filgrastim compared with single Pegfilgrastim in breast Cancer patients receiving adjuvant Docetaxel, doxorubicin, and cyclophosphamide (TAC) chemotherapyByeong Seok Sohn, Jae Ho Jeong, Jin-Hee Ahn, et al.Investigational New Drugs|January 1, 1986
CI-921: an analog of amsacrine with experimental activity against solid tumorsW R Grove, L W DeLap, A J Grillo-LópezInvestigational New Drugs|July 2, 2021
Network pharmacology of triptolide in cancer cells: implications for transcription factor bindingEan-Jeong Seo, Mona Dawood, Annika K Hult, et al.Pageof 372